Cohort for predicting gastric cancer in patients with intestinal metaplasia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to establish a cohort of patients diagnosed with intestinal metaplasia to monitor the progression to gastric cancer over time. Patients at Seoul National University Hospital who have previously been diagnosed with intestinal metaplasia will undergo endoscopic procedures to collect tissue samples for histological analysis. These samples will be used to assess the severity of intestinal metaplasia and to identify potential biomarkers associated with the development of gastric cancer. Participants will be followed up with routine endoscopies to track any progression to cancer.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients who visit Seoul National University Hospital
* Patients who have been visually diagnosed with intestinal metaplasia at a prior exam

Exclusion Criteria:

* Patients who have been previously diagnosed with gastric cancer or adenoma
* Patients who have previously received gastrectomy

Where it's running

• Seoul National University Hospital
  Seoul, South Korea Recruiting

Study contacts

• Principal investigator: Soo-Jeong Cho, MD, PhD — Seoul National University Hospital
• Study coordinator: Soo-Jeong Cho, MD, PhD
• Email: crystal5@snu.ac.kr
• Phone: 02-2072-4073

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prevalence and possible role of non-H. pylori Helicobacter species in gastric conditions and cancers

  Researchers will test stomach tissue from people with functional dyspeasia, various gastritis conditions, gastric cancer, and bariatric patients to see if non-H. pylori Helicobacter species are present.

  Recruiting at 3 sites Universiteit Antwerpen · Edegem and 2 other locations · NCT07770126

• AI-assisted EGGIM scoring for gastric intestinal metaplasia

  This study tests if an AI tool can automatically calculate EGGIM scores from endoscopy images to measure gastric intestinal metaplasia in adults undergoing image-enhanced endoscopy.

  Recruiting Qilu Hospital of Shandong University · Jinan, Shandong and 2 other locations · NCT07257796

• Observational study on gastric precancerous conditions

  This study looks at people who are at higher risk for stomach cancer to see how conditions like atrophic gastritis and intestinal metaplasia develop over time.

  Recruiting Stanford University · Stanford, California · NCT04191551

• AI-assisted scoring for gastric IM using EGGIM shows how well doctors trained

  This trial tests whether AI-assisted EGGIM scoring helps endoscopists better identify gastric intestinal metaplasia in patients.

  Recruiting Qilu Hospital of Shandong University · Jinan, Shandong · NCT07208864

• Ursodeoxycholic acid for reversing gastric intestinal metaplasia

  This study will test whether taking ursodeoxycholic acid for six months can reverse gastric intestinal metaplasia in adults who do not have Helicobacter pylori infection.

  Recruiting at 6 sites Phase 4 Xijing Hospital of Digestive Diseases · Pingdingshan, Henan and 5 other locations · NCT06610760

• Weifuchun tablets versus folic acid to reverse gastric intestinal metaplasia

  This trial tries to see if taking Weifuchun tablets daily for six months can reverse gastric intestinal metaplasia in adults without Helicobacter pylori compared with daily folic acid.

  Recruiting at 9 sites Phase 4 Xijing Hospital of Digestive Diseases · Ankang and 8 other locations · NCT06610266

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.